Skip to content Skip to navigation

Publications

Export 10 results:
Author Title Type [ Year(Asc)]
Filters: Author is Z. Cai  [Clear All Filters]
2020
Yook, S.; Cai, Z.; Jeong, J. J.; Lu, Y.; Winnik, M. A.; Pignol, J. - P.; Reilly, R. M. A Dual Receptor-Targeted (Drt) Radiation Nanomedicine Labeled With 177Lu Is More Potent For Killing Human Breast Cancer Cells In Vitro That Co-Express Her2 And Egfr Than Single Receptor-Targeted (Srt) Radiation Nanomedicines. Mol. Pharmaceutics 2020, 17, 1226–1236.
2019
Aghevlian, S.; Cai, Z.; Lu, Y.; Hedley, D.; Winnik, M. A.; Reilly*, R. M. Radioimmunotherapy Of Egfr-Positive Panc-1 Human Pancreatic Cancer Xenografts In Nrg Mice With Panitumumab Modified With Metal-Chelating Polymers (Mcp) Complexed To 177Lu. Molec. r Pharmaceutics 2019, 16, 768–778.
2017
Cai, Z.; Yook, S.; Lu, Y.; Bergstrom, D.; Winnik, M. A.; Pignol, J. - P.; Reilly, R. M. Local Radiation Treatment Of Her2-Positive Breast Cancer Using Trastuzumab-Modified Gold Nanoparticles Labeled With 177Lu. Pharmaceutical Research 2017, 34, 579–590.
Lai, P.; Cai, Z.; Pignol, J. - P.; Lechtman, E.; Mashouf, S.; Lu, Y.; Winnik, M. A.; Jaffray, D. A.; Reilly, R. M. Onte Carlo Simulation Of Radiation Transport And Dose Deposition From Locally Released Gold Nanoparticles Labeled With 111In, 177Lu Or 90Y Incorporated Into Tissue Implantable Depots. Physics in Medicine and Biology 2017, 62, 8581–8599.
2016
Yook, S.; Cai, Z.; Lu, Y.; Winnik, M. A.; Pignol, J.; Reilly*, R. M. Intratumorally Injected 177Lu-Labeled Gold Nanoparticles: Gold Nanoseed Brachytherapy With Application For Neoadjuvant Treatment Of Locally Advanced Breast Cancer. J. Nucl. Med. 2016, 57, 936–942.
Yook, S.; Lu, Y.; Jeong, J. J.; Cai, Z.; Tong, L.; Alwarda, R.; Pignol, J. P.; Winnik, M. A.; Reilly*, R. M. Stability And Biodistribution Of Thiol-Functionalized And 177Lu-Labeled Metal Chelating Polymers (Mcp) Bound To Gold Nanoparticles. Biomacromolecules 2016, 17, 1292–1302.
2015
Yook, S.; Cai, Z.; Lu, Y.; Winnik, M. A.; Pignol, J.; Reilly*, R. M. Radiation Nanomedicine For Egfr-Positive Breast Cancer Panitumumab Modified Gold Nanoparticles Complexed To The - Particle-Emitter, 177Lu. Mol. Pharmaceutics 2015, 12, 3963–72.
Mbong, G. N. N.; Lu, Y.; Chan, C.; Cai, Z.; Liu, P.; Boyle, A. J.; Winnik*, M. A.; Reilly*, R. M. Trastuzumab Labeled To High Specific Activity With 111In By Site-Specific Conjugation To A Metal-Chelating Polymer Exhibits Auger Electron-Mediated Cytoxicity On Her2-Positive Breast Cancer Cells. Mol. Pharmaceutics 2015, 12, 1951–1960.
2014
Liu, P.; Cai, Z.; Kang, J.; Boyle, A. J.; Lu, Y.; G. Mbong, N. Ndjock; Reilly*, R. M.; Winnik*, M. A. Intracellular Routing In Breast Cancer Cells Of Streptavidin-Conjugated Trastuzumab Fab Fragments Linked To Biotinylated Doxorubicin-Functionalized Metal Chelating Polymers. Biomacromolecules 2014, 15, 715–725.
Lu, Y.; G. Mbong, N. Ndjock; Liu, P.; Chan, C.; Cai, Z.; Weinrich, D.; Reilly*, R. M.; Winnik*, M. A. Synthesis Of Polyglutamide Based Metal Chelating Polymers And Their Site-Specific Conjugation To Trastuzumab For Auger Electrons Radioimmunotherapy; Biomacromolecules; 2014; Vol. 15, pp 2027–2037.